UPDATE: Morgan Stanley Downgrades Cyteir Therapeutics (CYT) to Equalweight
Tweet Send to a Friend
(Updated - September 9, 2022 5:32 AM EDT)
Morgan Stanley analyst Jeffrey Hung downgraded Cyteir Therapeutics (NASDAQ: CYT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Jeffrey Hung downgraded Cyteir Therapeutics (NASDAQ: CYT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
